Medifast (MED) Tops Q2 EPS by 65c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $10.70 -2.99%
Revenue Growth %: -29.3%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: -29.3%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q2 EPS of $3.96, $0.65 better than the analyst estimate of $3.31. Revenue for the quarter came in at $394.2 million versus the consensus estimate of $358.45 million.
GUIDANCE:
Medifast sees Q3 2021 EPS of $12.70-$14.17, versus the consensus of $13.80. Medifast sees Q3 2021 revenue of $1.425-1.525 million, versus the consensus of $1.46 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan cuts estimates for Circle and Coinbase on Hyperliquid pressure
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- Citigroup (C) Tops Q2 EPS by 42c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
